National Drug Code (NDC) Database
Towa Pharmaceutical Europe, S.L.
-
NDC:
73476-750
-
Nonproprietary Name:
DULOXETINE HYDROCHLORIDE
-
Dosage Form:
CAPSULE, DELAYED RELEASE PELLETS
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
40 mg/1
-
Substance:
DULOXETINE HYDROCHLORIDE
-
Start Marketing Date:
2018-06-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TOYOBO CO., LTD.
-
NDC:
72639-0011
-
Nonproprietary Name:
mogamulizumab
-
Dosage Form:
INJECTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
4 mg/mL
-
Substance:
MOGAMULIZUMAB
-
Start Marketing Date:
2018-08-08
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Trifarma S.p.A.
-
NDC:
46204-0371
-
Nonproprietary Name:
Testosterone Cypionate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
TESTOSTERONE CYPIONATE
-
Start Marketing Date:
2019-09-02
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CIII
-
Certified Through:
2026-12-31
Trifluoperazine Hydrochloride
-
NDC:
46204-0081
-
Nonproprietary Name:
Trifluoperazine Hydrochloride
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
TRIFLUOPERAZINE HYDROCHLORIDE
-
Start Marketing Date:
2012-08-16
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Trillium Health Care Products Inc.
-
NDC:
53592-221
-
Nonproprietary Name:
Phenylephrine Hydrochloride
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
22.2 g/kg
-
Substance:
PHENYLEPHRINE HYDROCHLORIDE
-
Start Marketing Date:
2022-01-31
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TRUECARE BIOMEDIX
-
NDC:
55132-038
-
Nonproprietary Name:
Aspirin
-
Dosage Form:
TABLET, COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
81 mg/1
-
Substance:
ASPIRIN
-
Start Marketing Date:
2024-05-08
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TYCHE INDUSTRIES LIMITED
-
NDC:
60862-008
-
Nonproprietary Name:
TOLVAPTAN
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
100 kg/100kg
-
Substance:
TOLVAPTAN
-
Start Marketing Date:
2019-08-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
UBE Corporation
-
NDC:
42672-0100
-
Nonproprietary Name:
Bepotastine
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
BEPOTASTINE BESILATE
-
Start Marketing Date:
2009-08-20
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
13668-734
-
Nonproprietary Name:
Lamotrigine
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
LAMOTRIGINE
-
Start Marketing Date:
2024-10-04
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Create a New Buying Request
Fields marked with * are mandatory.